419 related articles for article (PubMed ID: 30839094)
1. Tripterygium glycoside protects diabetic kidney disease mouse serum-induced podocyte injury by upregulating autophagy and downregulating β-arrestin-1.
Zhan H; Jin J; Liang S; Zhao L; Gong J; He Q
Histol Histopathol; 2019 Aug; 34(8):943-952. PubMed ID: 30839094
[TBL] [Abstract][Full Text] [Related]
2. Tripterygium glycoside suppresses epithelial‑to‑mesenchymal transition of diabetic kidney disease podocytes by targeting autophagy through the mTOR/Twist1 pathway.
Tao M; Zheng D; Liang X; Wu D; Hu K; Jin J; He Q
Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34165172
[TBL] [Abstract][Full Text] [Related]
3. Tripterygium glycoside protects against puromycin amino nucleoside‑induced podocyte injury by upregulating autophagy.
Gong J; Jin J; Zhao L; Li Y; Li Y; He Q
Int J Mol Med; 2018 Jul; 42(1):115-122. PubMed ID: 29620171
[TBL] [Abstract][Full Text] [Related]
4. β-Arrestin 1/2 Aggravates Podocyte Apoptosis of Diabetic Nephropathy via Wnt/β-Catenin Pathway.
Wang Y; Li H; Song SP
Med Sci Monit; 2018 Mar; 24():1724-1732. PubMed ID: 29572435
[TBL] [Abstract][Full Text] [Related]
5. Wogonin protects glomerular podocytes by targeting Bcl-2-mediated autophagy and apoptosis in diabetic kidney disease.
Liu XQ; Jiang L; Li YY; Huang YB; Hu XR; Zhu W; Wang X; Wu YG; Meng XM; Qi XM
Acta Pharmacol Sin; 2022 Jan; 43(1):96-110. PubMed ID: 34253875
[TBL] [Abstract][Full Text] [Related]
6. [The effects and mechanism of Tripterygium wilfordii Hook F combination with irbesartan on urinary podocyte excretion in diabetic nephropathy patients].
Ma RX; Zhao N; Zhang W
Zhonghua Nei Ke Za Zhi; 2013 Jun; 52(6):469-73. PubMed ID: 24059992
[TBL] [Abstract][Full Text] [Related]
7. The novel involvement of podocyte autophagic activity in the pathogenesis of lupus nephritis.
Jin J; Ye M; Zhao L; Zou W; Shen W; Zhang H; Gong J; He Q
Histol Histopathol; 2018 Aug; 33(8):803-814. PubMed ID: 29446059
[TBL] [Abstract][Full Text] [Related]
8. p66Shc regulates podocyte autophagy in high glucose environment through the Notch-PTEN-PI3K/Akt/mTOR pathway.
Zheng D; Tao M; Liang X; Li Y; Jin J; He Q
Histol Histopathol; 2020 Apr; 35(4):405-415. PubMed ID: 31650524
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D Ameliorates Podocyte Injury by Enhancing Autophagy Activity in Diabetic Kidney Disease.
Zhang X; Zhang L; Wen Y; Zhang M; Liu S; Xiao H
Kidney Blood Press Res; 2023; 48(1):314-325. PubMed ID: 37054686
[TBL] [Abstract][Full Text] [Related]
10. Jiedu Tongluo Baoshen formula enhances podocyte autophagy and reduces proteinuria in diabetic kidney disease by inhibiting PI3K/Akt/mTOR signaling pathway.
Jin D; Liu F; Yu M; Zhao Y; Yan G; Xue J; Sun Y; Zhao D; Li X; Qi W; Wang X
J Ethnopharmacol; 2022 Jul; 293():115246. PubMed ID: 35398500
[TBL] [Abstract][Full Text] [Related]
11. MYDGF attenuates podocyte injury and proteinuria by activating Akt/BAD signal pathway in mice with diabetic kidney disease.
He M; Li Y; Wang L; Guo B; Mei W; Zhu B; Zhang J; Ding Y; Meng B; Zhang L; Xiang L; Dong J; Liu M; Xiang L; Xiang G
Diabetologia; 2020 Sep; 63(9):1916-1931. PubMed ID: 32588068
[TBL] [Abstract][Full Text] [Related]
12. β-Arrestins promote podocyte injury by inhibition of autophagy in diabetic nephropathy.
Liu J; Li QX; Wang XJ; Zhang C; Duan YQ; Wang ZY; Zhang Y; Yu X; Li NJ; Sun JP; Yi F
Cell Death Dis; 2016 Apr; 7(4):e2183. PubMed ID: 27054338
[TBL] [Abstract][Full Text] [Related]
13. Placenta-derived mesenchymal stem cells protect against diabetic kidney disease by upregulating autophagy-mediated SIRT1/FOXO1 pathway.
Liu H; Wang J; Yue G; Xu J
Ren Fail; 2024 Dec; 46(1):2303396. PubMed ID: 38234193
[TBL] [Abstract][Full Text] [Related]
14. JAK/STAT pathway promotes the progression of diabetic kidney disease via autophagy in podocytes.
Chen D; Liu Y; Chen J; Lin H; Guo H; Wu Y; Xu Y; Zhou Y; Zhou W; Lu R; Zhou J; Wu J
Eur J Pharmacol; 2021 Jul; 902():174121. PubMed ID: 33901462
[TBL] [Abstract][Full Text] [Related]
15. STIM promotes the epithelial-mesenchymal transition of podocytes through regulation of FcγRII activity in diabetic nephropathy.
Jin J; Ye M; Hu K; Gong J; He Q
Histol Histopathol; 2019 Jun; 34(6):671-682. PubMed ID: 30475382
[TBL] [Abstract][Full Text] [Related]
16. Qizhi Jiangtang capsule activates podocyte autophagy in diabetic kidney disease by inhibiting phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin pathways.
Zhaoan G; Lina S; Yingying L; Ruifeng LI; Chong L; Ke D; Jing S; Jun S
J Tradit Chin Med; 2023 Aug; 43(4):667-675. PubMed ID: 37454251
[TBL] [Abstract][Full Text] [Related]
17. Tangshen formula protects against podocyte apoptosis via enhancing the TFEB-mediated autophagy-lysosome pathway in diabetic nephropathy.
Wang Y; Peng L; Lu X; Zhang H; Zhao H; Zhao T; Yang L; Mao H; Ma F; Liu T; Li P; Zhan Y
J Ethnopharmacol; 2024 Apr; 324():117721. PubMed ID: 38199335
[TBL] [Abstract][Full Text] [Related]
18. Tongluo Digui decoction treats renal injury in diabetic rats by promoting autophagy of podocytes.
Han J; Zhang Y; Shi X; Peng Z; Xing Y; Pang X
J Tradit Chin Med; 2021 Feb; 41(1):125-132. PubMed ID: 33522205
[TBL] [Abstract][Full Text] [Related]
19. Berberine mitigates high glucose-induced podocyte apoptosis by modulating autophagy via the mTOR/P70S6K/4EBP1 pathway.
Li C; Guan XM; Wang RY; Xie YS; Zhou H; Ni WJ; Tang LQ
Life Sci; 2020 Feb; 243():117277. PubMed ID: 31926252
[TBL] [Abstract][Full Text] [Related]
20. Krüppel‑like factor 4 ameliorates diabetic kidney disease by activating autophagy via the mTOR pathway.
Gong J; Zhan H; Li Y; Zhang W; Jin J; He Q
Mol Med Rep; 2019 Oct; 20(4):3240-3248. PubMed ID: 31432191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]